|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||84.49 - 85.68|
|52 Week Range||53.15 - 85.68|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.35%|
The following is original research by ARK's Genomic Revolution Analyst, Manisha Samy . Genome-Editing During the past decade, technology breakthroughs enabling the modification of complex genomes have changed the primary goal of research in ...
Prime Minister May Looks to Bolster the Sector Earlier this year, Prime Minister Theresa May earmarked life sciences as one of five areas critical to the UK’s economic growth and commissioned a proposal on how to bolster the sector, especially as the ...
The iShares NASDAQ Biotechnology ETF (IBB) is an open-end fund with assets under management of $9.85 billion.